{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:38:23Z","timestamp":1777055903119,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CRRPG2H0121-124"],"award-info":[{"award-number":["CRRPG2H0121-124"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG2H000091-0093"],"award-info":[{"award-number":["CMRPG2H000091-0093"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CLRPG2L0051"],"award-info":[{"award-number":["CLRPG2L0051"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG2K0141-142"],"award-info":[{"award-number":["CMRPG2K0141-142"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["PD-109-GP-02"],"award-info":[{"award-number":["PD-109-GP-02"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["PD-109-GP-03"],"award-info":[{"award-number":["PD-109-GP-03"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetic kidney disease is the leading cause of end-stage kidney disease worldwide; however, the integration of high-dimensional trans-omics data to predict this diabetic complication is rare. We develop artificial intelligence (AI)-assisted models using machine learning algorithms to identify a biomarker signature that predisposes high risk patients with diabetes mellitus (DM) to diabetic kidney disease based on clinical information, untargeted metabolomics, targeted lipidomics and genome-wide single nucleotide polymorphism (SNP) datasets. This involves 618 individuals who are split into training and testing cohorts of 557 and 61 subjects, respectively. Three models are developed. In model 1, the top 20 features selected by AI give an accuracy rate of 0.83 and an area under curve (AUC) of 0.89 when differentiating DM and non-DM individuals. In model 2, among DM patients, a biomarker signature of 10 AI-selected features gives an accuracy rate of 0.70 and an AUC of 0.76 when identifying subjects at high risk of renal impairment. In model 3, among non-DM patients, a biomarker signature of 25 AI-selected features gives an accuracy rate of 0.82 and an AUC of 0.76 when pinpointing subjects at high risk of chronic kidney disease. In addition, the performance of the three models is rigorously verified using an independent validation cohort. Intriguingly, analysis of the protein\u2013protein interaction network of the genes containing the identified SNPs (RPTOR, CLPTM1L, ALDH1L1, LY6D, PCDH9, B3GNTL1, CDS1, ADCYAP and FAM53A) reveals that, at the molecular level, there seems to be interconnected factors that have an effect on the progression of renal impairment among DM patients. In conclusion, our findings reveal the potential of employing machine learning algorithms to augment traditional methods and our findings suggest what molecular mechanisms may underlie the complex interaction between DM and chronic kidney disease. Moreover, the development of our AI-assisted models will improve precision when diagnosing renal impairment in predisposed patients, both DM and non-DM. Finally, a large prospective cohort study is needed to validate the clinical utility and mechanistic implications of these biomarker signatures.<\/jats:p>","DOI":"10.1038\/s41746-022-00713-7","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T20:29:15Z","timestamp":1667420955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease"],"prefix":"10.1038","volume":"5","author":[{"given":"I-Wen","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Hsien","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Jen","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ju","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hsiao","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Hsuan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Wei-Che","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Chih","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Jung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chiau","family":"Shyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Lang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huey-Kang","family":"Sytwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3239-4430","authenticated-orcid":false,"given":"Ting-Fen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"713_CR1","unstructured":"WHO. Improving Health Outcomes of People with Diabetes Mellitus: Target Setting to Reduce the Global Burden of Diabetes Mellitus by 2030. https:\/\/www.who.int\/publications\/m\/item\/improving-health-outcomes-of-people-with-diabetes-mellitus (2021)."},{"key":"713_CR2","unstructured":"Federation, I. D. IDF Diabetes Atlas. 9th edn 2019 (accessed 13 September 2021) www.diabetesatlas.org."},{"key":"713_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41581-020-00367-2","volume":"17","author":"RZ Alicic","year":"2021","unstructured":"Alicic, R. Z., Cox, E. J., Neumiller, J. J. & Tuttle, K. R. Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence. Nat. Rev. Nephrol. 17, 227\u2013244 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"713_CR4","unstructured":"System, U. S. R. D. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD)."},{"key":"713_CR5","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster, A. C., Nagler, E. V., Morton, R. L. & Masson, P. Chronic kidney disease. Lancet 389, 1238\u20131252 (2017).","journal-title":"Lancet"},{"key":"713_CR6","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(08)60952-6","volume":"371","author":"CP Wen","year":"2008","unstructured":"Wen, C. P. et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 371, 2173\u20132182 (2008).","journal-title":"Lancet"},{"key":"713_CR7","unstructured":"GBD Chronic Kidney Disease Collaboration, Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709-733, (2020)."},{"key":"713_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41581-019-0191-y","volume":"16","author":"AS Levey","year":"2020","unstructured":"Levey, A. S., Coresh, J., Tighiouart, H., Greene, T. & Inker, L. A. Measured and estimated glomerular filtration rate: current status and future directions. Nat. Rev. Nephrol. 16, 51\u201364 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"713_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo, R. A., Reeves, W. B. & Awad, A. S. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat. Rev. Nephrol. 17, 319\u2013334 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"713_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1053\/j.ajkd.2013.10.010","volume":"63","author":"M van de Vrie","year":"2014","unstructured":"van de Vrie, M., Deegens, J. K., van der Vlag, J. & Hilbrands, L. B. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL). Am. J. Kidney Dis. 63, 573\u2013576 (2014).","journal-title":"Am. J. Kidney Dis."},{"key":"713_CR11","doi-asserted-by":"publisher","first-page":"914587","DOI":"10.3389\/fmed.2022.914587","volume":"9","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Xue, S., Wu, M. & Dong, D. Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: a meta-analysis. Front Med. (Lausanne) 9, 914587 (2022).","journal-title":"Front Med. (Lausanne)"},{"key":"713_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","volume":"14","author":"HJ Anders","year":"2018","unstructured":"Anders, H. J., Huber, T. B., Isermann, B. & Schiffer, M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat. Rev. Nephrol. 14, 361\u2013377 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"713_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","volume":"76","author":"AS Allegretti","year":"2020","unstructured":"Allegretti, A. S., Sola, E. & Gines, P. Clinical application of kidney biomarkers in cirrhosis. Am. J. Kidney Dis. 76, 710\u2013719 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"713_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","volume":"16","author":"V Vallon","year":"2020","unstructured":"Vallon, V. & Thomson, S. C. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat. Rev. Nephrol. 16, 317\u2013336 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"713_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrneph.2017.30","volume":"13","author":"B Hocher","year":"2017","unstructured":"Hocher, B. & Adamski, J. Metabolomics for clinical use and research in chronic kidney disease. Nat. Rev. Nephrol. 13, 269\u2013284 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"713_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","volume":"15","author":"M Kato","year":"2019","unstructured":"Kato, M. & Natarajan, R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat. Rev. Nephrol. 15, 327\u2013345 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"713_CR17","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2337\/dc19-2348","volume":"43","author":"JA Bell","year":"2020","unstructured":"Bell, J. A. et al. Early metabolic features of genetic liability to type 2 diabetes: cohort study with repeated metabolomics across early life. Diabetes Care 43, 1537\u20131545 (2020).","journal-title":"Diabetes Care"},{"key":"713_CR18","first-page":"717","volume":"41","author":"M Hiramoto","year":"2018","unstructured":"Hiramoto, M. et al. A type 2 diabetes-associated SNP in KCNQ1 (rs163184) modulates the binding activity of the locus for Sp3 and Lsd1\/Kdm1a, potentially affecting CDKN1C expression. Int J. Mol. Med. 41, 717\u2013728 (2018).","journal-title":"Int J. Mol. Med."},{"key":"713_CR19","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"713_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred, R. et al. The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 30, 187\u2013200 (2021).","journal-title":"Protein Sci."},{"key":"713_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41588-018-0160-6","volume":"50","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk. Nat. Genet 50, 1171\u20131179 (2018).","journal-title":"Nat. Genet"},{"key":"713_CR22","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1093\/bioinformatics\/btz114","volume":"35","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. Differential network enrichment analysis reveals novel lipid pathways in chronic kidney disease. Bioinformatics 35, 3441\u20133452 (2019).","journal-title":"Bioinformatics"},{"key":"713_CR23","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. Serum integrative omics reveals the landscape of human diabetic kidney disease. Mol. Metab. 101367, https:\/\/doi.org\/10.1016\/j.molmet.2021.101367 (2021).","DOI":"10.1016\/j.molmet.2021.101367"},{"key":"713_CR24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.kint.2020.02.028","volume":"97","author":"RSG Sealfon","year":"2020","unstructured":"Sealfon, R. S. G., Mariani, L. H., Kretzler, M. & Troyanskaya, O. G. Machine learning, the kidney, and genotype-phenotype analysis. Kidney Int. 97, 1141\u20131149 (2020).","journal-title":"Kidney Int."},{"key":"713_CR25","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.numecd.2021.04.021","volume":"31","author":"A Roointan","year":"2021","unstructured":"Roointan, A., Gheisari, Y., Hudkins, K. L. & Gholaminejad, A. Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies. Nutr. Metab. Cardiovasc Dis. 31, 2253\u20132272 (2021).","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"713_CR26","doi-asserted-by":"publisher","unstructured":"Tan, Y. M. et al. Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy. Metabolites 11, https:\/\/doi.org\/10.3390\/metabo11040228 (2021).","DOI":"10.3390\/metabo11040228"},{"key":"713_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2337\/dc16-0173","volume":"40","author":"MA Niewczas","year":"2017","unstructured":"Niewczas, M. A. et al. Circulating modified metabolites and a risk of ESRD in patients with type 1 diabetes and chronic kidney disease. Diabetes Care 40, 383\u2013390 (2017).","journal-title":"Diabetes Care"},{"key":"713_CR28","doi-asserted-by":"publisher","unstructured":"Huang, J. et al. Validation of Candidate Phospholipid Biomarkers of Chronic Kidney Disease in Hyperglycemic Individuals and Their Organ-Specific Exploration in Leptin Receptor-Deficient db\/db Mouse. Metabolites 11, https:\/\/doi.org\/10.3390\/metabo11020089 (2021).","DOI":"10.3390\/metabo11020089"},{"key":"713_CR29","doi-asserted-by":"publisher","unstructured":"Sun, Y., Gao, H. Y., Fan, Z. Y., He, Y. & Yan, Y. X. Metabolomics signatures in type 2 diabetes: a systematic review and integrative analysis. J. Clin. Endocrinol Metab. 105, https:\/\/doi.org\/10.1210\/clinem\/dgz240 (2020).","DOI":"10.1210\/clinem\/dgz240"},{"key":"713_CR30","doi-asserted-by":"publisher","unstructured":"Zakrocka, I. & Za\u0142uska, W. Kynurenine pathway in kidney diseases. Pharmacol Rep. https:\/\/doi.org\/10.1007\/s43440-021-00329-w (2021).","DOI":"10.1007\/s43440-021-00329-w"},{"key":"713_CR31","doi-asserted-by":"publisher","unstructured":"Arinze, N. V. et al. Tryptophan metabolites suppress Wnt pathway and promote adverse limb events in CKD patients. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci142260 (2021).","DOI":"10.1172\/jci142260"},{"key":"713_CR32","unstructured":"Wee, H. N., Liu, J. J., Ching, J., Kovalik, J. P. & Lim, S. C. The kynurenine pathway in acute kidney injury and chronic kidney disease. Am. J. Nephrol. 1\u201317 (2021)."},{"key":"713_CR33","doi-asserted-by":"publisher","first-page":"117864691769460","DOI":"10.1177\/1178646917694600","volume":"10","author":"S Debnath","year":"2017","unstructured":"Debnath, S. et al. Tryptophan metabolism in patients with chronic kidney disease secondary to type 2 diabetes: relationship to inflammatory markers. Int. J. Tryptophan Res. 10, 1178646917694600 (2017).","journal-title":"Int. J. Tryptophan Res."},{"key":"713_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2017.08.002","volume":"64","author":"CN Serhan","year":"2018","unstructured":"Serhan, C. N., Chiang, N. & Dalli, J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol. Asp. Med. 64, 1\u201317 (2018).","journal-title":"Mol. Asp. Med."},{"key":"713_CR35","doi-asserted-by":"publisher","unstructured":"Yaribeygi, H., Atkin, S. L., Simental-Mendia, L. E., Barreto, G. E. & Sahebkar, A. Anti-inflammatory effects of resolvins in diabetic nephropathy: Mechanistic pathways. J. Cell Physiol. https:\/\/doi.org\/10.1002\/jcp.28315 (2019).","DOI":"10.1002\/jcp.28315"},{"key":"713_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41581-020-0286-5","volume":"16","author":"S Eddy","year":"2020","unstructured":"Eddy, S., Mariani, L. H. & Kretzler, M. Integrated multi-omics approaches to improve classification of chronic kidney disease. Nat. Rev. Nephrol. 16, 657\u2013668 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"713_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","volume":"16","author":"JB Cole","year":"2020","unstructured":"Cole, J. B. & Florez, J. C. Genetics of diabetes mellitus and diabetes complications. Nat. Rev. Nephrol. 16, 377\u2013390 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"713_CR38","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1681\/ASN.2019030218","volume":"30","author":"RM Salem","year":"2019","unstructured":"Salem, R. M. et al. Genome-wide association study of diabetic kidney disease highlights biology involved in glomerular basement membrane collagen. J. Am. Soc. Nephrol. 30, 2000\u20132016 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"713_CR39","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.kint.2017.01.007","volume":"91","author":"GM McMahon","year":"2017","unstructured":"McMahon, G. M. et al. Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease. Kidney Int. 91, 1426\u20131435 (2017).","journal-title":"Kidney Int."},{"key":"713_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/nep.13479","volume":"24","author":"R Fujii","year":"2019","unstructured":"Fujii, R. et al. Association of genetic risk score and chronic kidney disease in a Japanese population. Nephrol. (Carlton) 24, 670\u2013673 (2019).","journal-title":"Nephrol. (Carlton)"},{"key":"713_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56400-3","volume":"9","author":"LN Liao","year":"2019","unstructured":"Liao, L. N. et al. Genetic risk score for risk prediction of diabetic nephropathy in Han Chinese type 2 diabetes patients. Sci. Rep. 9, 19897 (2019).","journal-title":"Sci. Rep."},{"key":"713_CR42","doi-asserted-by":"publisher","first-page":"110912","DOI":"10.1016\/j.mce.2020.110912","volume":"518","author":"SJ Winters","year":"2020","unstructured":"Winters, S. J. & Moore, J. P. Jr. PACAP: a regulator of mammalian reproductive function. Mol. Cell Endocrinol. 518, 110912 (2020).","journal-title":"Mol. Cell Endocrinol."},{"key":"713_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MAJ.0b013e31816740e3","volume":"336","author":"IW Wu","year":"2008","unstructured":"Wu, I. W., Hung, M. J., Chen, Y. C., Cherng, W. J. & Wu, M. S. High body mass index is not associated with coronary artery disease in angina patients with chronic kidney disease: a coronary angiography study. Am. J. Med Sci. 336, 303\u2013308 (2008).","journal-title":"Am. J. Med Sci."},{"key":"713_CR44","unstructured":"National Kidney Foundation: K\/DOQI Clinical practice guidelines for Chronic Kidney Disease: Evaluation, classification and stratification. Am J Kidney Dis 39, S1-S266 (2002)."},{"key":"713_CR45","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","volume":"65","author":"ML Cheng","year":"2015","unstructured":"Cheng, M. L. et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J. Am. Coll. Cardiol. 65, 1509\u20131520 (2015).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-022-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-022-00713-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-022-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T21:11:10Z","timestamp":1667423470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-022-00713-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["713"],"URL":"https:\/\/doi.org\/10.1038\/s41746-022-00713-7","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"4 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}